Every time Dave publishes a story, you’ll get an alert straight to your inbox! Enter your email By clicking “Sign up”, you agree to receive emails from Business ...
Watch as I create mesmerizing acrylic pour and marbling art! From my first dirty pour to silk marbling, each piece comes alive with vibrant colors and flowing designs. Perfect for art lovers, DIY ...
Clear ice not only looks nice, but also prevents over dilution in your drink. You can make clear ice using the cooler method or by using molds.
There are a number of iPad apps that can help you explore and express your creativity. Although the iPad started off as a simple device that could be used to stream content or browse the web on the go ...
The N64 has a bit of a bad rap, mainly from people who weren’t around in its glory years. For those who were, it was absolute magic, and still is. But from a more modern lens, it’s viewed as a console ...
But the real treasures are the local boutiques that give The Market Common its distinctive South Carolina flavor. Shops like Coastal Urge offer beach-inspired clothing and accessories that remind you ...
Platforms like Stats Edge and GRID Insights have made such systems commercially viable, combining player and team data, projection engines, real-time match tracking, and predictive features. GRID ...
Some local game developers are pushing themselves to the limit starting Friday at the New Mexico Game Jam. KOB 4 Photojournalist Zack Crozier has a preview on what it’s like to feel the crunch.
Until they reached out to invite me to Japan this year, I’d never heard of Shochiku. That’s because it began as a kabuki company, and is a relative newcomer to the games space despite being a major ...
With the rapid development of smart connected vehicles, automotive intelligence has become a key focus for car manufacturers for a long time to come. Among these, the smart vehicle system plays an ...
Earlier this week, Esperion Therapeutics completed a follow-on public offering of 30,000,000 shares of its common stock at US$2.50 per share, raising total gross proceeds of approximately US$75 ...
NewAmsterdam Pharma Company N.V. recently saw a spike in trader interest following optimism around its investigational drug candidate, obicetrapib, which is undergoing three pivotal late-stage trials ...